SAN FRANCISCO (GenomeWeb) – Researchers at Seattle Children's Hospital have launched a clinical trial that aims to identify the immune pathways involved in inflammatory bowel disease and in patients who undergo bone marrow transplantation and develop graft versus host disease of the gastrointestinal tract.

The goal is to identify immune system-related gene expression signatures that can lead to better diagnosis of the diseases, enabling subtyping to identify the most severe cases, and even to enable targeted treatment.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.